Matches in SemOpenAlex for { <https://semopenalex.org/work/W3045407788> ?p ?o ?g. }
- W3045407788 endingPage "1070" @default.
- W3045407788 startingPage "1058" @default.
- W3045407788 abstract "Abstract Background Most prostate cancers express androgen receptor (AR), and our previous studies have focused on identifying transcription factors that modify AR function. We have shown that nuclear factor I/B (NFIB) regulates AR activity in androgen‐dependent prostate cancer cells in vitro. However, the status of NFIB in prostate cancer was unknown. Methods We immunostained a tissue microarray including normal, hyperplastic, prostatic intraepithelial neoplasia, primary prostatic adenocarcinoma, and castration‐resistant prostate cancer tissue samples for NFIB, AR, and synaptophysin, a marker of neuroendocrine differentiation. We interrogated publically available data sets in cBioPortal to correlate NFIB expression and AR and neuroendocrine prostate cancer (NEPCa) activity scores. We analyzed prostate cancer cell lines for NFIB expression via Western blot analysis and used nuclear and cytoplasmic fractionation to assess where NFIB is localized. We performed co‐immunoprecipitation studies to determine if NFIB and AR interact. Results NFIB increased in the nucleus and cytoplasm of prostate cancer samples versus matched normal controls, independent of Gleason score. Similarly, cytoplasmic AR and synaptophysin increased in primary prostate cancer. We observed strong NFIB staining in primary small cell prostate cancer. The ratio of cytoplasmic‐to‐nuclear NFIB staining was predictive of earlier biochemical recurrence in prostate cancer, once adjusted for tumor margin status. Cytoplasmic AR was an independent predictor of biochemical recurrence. There was no statistically significant difference between NFIB and synaptophysin expression in primary and castration‐resistant prostate cancer, but cytoplasmic AR expression was increased in castration‐resistant samples. In primary prostate cancer, nuclear NFIB expression correlated with cytoplasmic NFIB and nuclear AR, while cytoplasmic NFIB correlated with synaptophysin, and nuclear and cytoplasmic AR. In castration‐resistant prostate cancer samples, NFIB expression correlated positively with an AR activity score, and negatively with the NEPCa score. In prostate cancer cell lines, NFIB exists in several isoforms. We observed NFIB predominantly in the nuclear fraction of prostate cancer cells with increased cytoplasmic expression seen in castration‐resistant cell lines. We observed an interaction between AR and NFIB through co‐immunoprecipitation experiments. Conclusion We have described the expression pattern of NFIB in primary and castration‐resistant prostate cancer and its positive correlation with AR. We have also demonstrated AR interacts with NFIB." @default.
- W3045407788 created "2020-07-29" @default.
- W3045407788 creator A5011503594 @default.
- W3045407788 creator A5020611529 @default.
- W3045407788 creator A5043963081 @default.
- W3045407788 creator A5045731475 @default.
- W3045407788 creator A5064908168 @default.
- W3045407788 creator A5065048797 @default.
- W3045407788 creator A5072204241 @default.
- W3045407788 creator A5081635691 @default.
- W3045407788 creator A5082583438 @default.
- W3045407788 date "2020-07-21" @default.
- W3045407788 modified "2023-10-15" @default.
- W3045407788 title "Increased nuclear factor I/B expression in prostate cancer correlates with AR expression" @default.
- W3045407788 cites W1541733924 @default.
- W3045407788 cites W1838945435 @default.
- W3045407788 cites W1920614447 @default.
- W3045407788 cites W1976491226 @default.
- W3045407788 cites W1982956208 @default.
- W3045407788 cites W1993434786 @default.
- W3045407788 cites W1995113386 @default.
- W3045407788 cites W1998691242 @default.
- W3045407788 cites W2003900378 @default.
- W3045407788 cites W2005020704 @default.
- W3045407788 cites W2016121119 @default.
- W3045407788 cites W2017437369 @default.
- W3045407788 cites W2018686658 @default.
- W3045407788 cites W2022609321 @default.
- W3045407788 cites W2025780443 @default.
- W3045407788 cites W2027844138 @default.
- W3045407788 cites W2038208558 @default.
- W3045407788 cites W2043449753 @default.
- W3045407788 cites W2045706913 @default.
- W3045407788 cites W2049467928 @default.
- W3045407788 cites W2050492297 @default.
- W3045407788 cites W2059233961 @default.
- W3045407788 cites W2061872473 @default.
- W3045407788 cites W2064360128 @default.
- W3045407788 cites W2071161597 @default.
- W3045407788 cites W2080914447 @default.
- W3045407788 cites W2082502831 @default.
- W3045407788 cites W2085139841 @default.
- W3045407788 cites W2085847636 @default.
- W3045407788 cites W2087448644 @default.
- W3045407788 cites W2089305758 @default.
- W3045407788 cites W2090263938 @default.
- W3045407788 cites W2092886494 @default.
- W3045407788 cites W2097027305 @default.
- W3045407788 cites W2097121410 @default.
- W3045407788 cites W2100281151 @default.
- W3045407788 cites W2114843025 @default.
- W3045407788 cites W2115408881 @default.
- W3045407788 cites W2130955565 @default.
- W3045407788 cites W2134745615 @default.
- W3045407788 cites W2144110960 @default.
- W3045407788 cites W2149441684 @default.
- W3045407788 cites W2149937232 @default.
- W3045407788 cites W2150329946 @default.
- W3045407788 cites W2150467310 @default.
- W3045407788 cites W2154226543 @default.
- W3045407788 cites W2157976596 @default.
- W3045407788 cites W2160298012 @default.
- W3045407788 cites W2163458728 @default.
- W3045407788 cites W2164980194 @default.
- W3045407788 cites W2165782799 @default.
- W3045407788 cites W2168108459 @default.
- W3045407788 cites W2171171429 @default.
- W3045407788 cites W2219316674 @default.
- W3045407788 cites W2219442002 @default.
- W3045407788 cites W2262087934 @default.
- W3045407788 cites W2267547239 @default.
- W3045407788 cites W2274972737 @default.
- W3045407788 cites W2316238957 @default.
- W3045407788 cites W2320168418 @default.
- W3045407788 cites W2518311324 @default.
- W3045407788 cites W2573527772 @default.
- W3045407788 cites W2759847459 @default.
- W3045407788 cites W2762381618 @default.
- W3045407788 cites W2841858285 @default.
- W3045407788 cites W2944403040 @default.
- W3045407788 cites W2948006642 @default.
- W3045407788 cites W3136918052 @default.
- W3045407788 doi "https://doi.org/10.1002/pros.24019" @default.
- W3045407788 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7434711" @default.
- W3045407788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32692871" @default.
- W3045407788 hasPublicationYear "2020" @default.
- W3045407788 type Work @default.
- W3045407788 sameAs 3045407788 @default.
- W3045407788 citedByCount "5" @default.
- W3045407788 countsByYear W30454077882021 @default.
- W3045407788 countsByYear W30454077882022 @default.
- W3045407788 countsByYear W30454077882023 @default.
- W3045407788 crossrefType "journal-article" @default.
- W3045407788 hasAuthorship W3045407788A5011503594 @default.
- W3045407788 hasAuthorship W3045407788A5020611529 @default.
- W3045407788 hasAuthorship W3045407788A5043963081 @default.
- W3045407788 hasAuthorship W3045407788A5045731475 @default.
- W3045407788 hasAuthorship W3045407788A5064908168 @default.